4-[7-(diethylamino)-2-imino-chromen-3-yl]-6-(4-phenylpiperazin-1-yl)-1,3,5-triazin-2-amine

ID: ALA5219557

PubChem CID: 168298850

Max Phase: Preclinical

Molecular Formula: C26H30N8O

Molecular Weight: 470.58

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCN(CC)c1ccc2cc(-c3nc(N)nc(N4CCN(c5ccccc5)CC4)n3)c(=N)oc2c1

Standard InChI:  InChI=1S/C26H30N8O/c1-3-32(4-2)20-11-10-18-16-21(23(27)35-22(18)17-20)24-29-25(28)31-26(30-24)34-14-12-33(13-15-34)19-8-6-5-7-9-19/h5-11,16-17,27H,3-4,12-15H2,1-2H3,(H2,28,29,30,31)

Standard InChI Key:  VZDQERSWDNKZPU-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
    0.0005    1.2375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0005    0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7139    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7150    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4295    0.4125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1440    0.0000    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4295    1.2375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7150    1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7150    2.4750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8586    0.4126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5733   -0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5732   -0.8252    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8585   -1.2378    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1439   -0.8252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2879   -1.2379    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0028   -0.8254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7149   -1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.7149   -2.0630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0046   -2.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2879   -2.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7138   -0.8252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4285   -1.2378    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1431   -0.8252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1432   -0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4286    0.4126    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8559   -1.2362    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5709   -0.8237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5727   -0.0026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8610    0.4140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0008   -1.2378    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2855   -1.2363    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -4.2855   -2.0616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0002   -0.8237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7149   -1.2363    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.0002   -2.4742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  2  0
  4  5  1  0
  5  6  1  0
  5  7  2  0
  7  8  1  0
  8  1  2  0
  8  9  1  0
 10  6  1  0
 11 10  1  0
 12 11  1  0
 13 12  1  0
 14 13  1  0
  6 14  1  0
 12 15  1  0
 16 15  2  0
 17 16  1  0
 18 17  2  0
 19 18  1  0
 20 19  2  0
 15 20  1  0
 21  3  1  0
 22 21  1  0
 23 22  1  0
 24 23  2  0
 25 24  1  0
  3 25  2  0
 23 26  1  0
 27 26  2  0
 28 27  1  0
 29 28  2  0
 24 29  1  0
 21 30  2  0
 27 31  1  0
 31 32  1  0
 31 33  1  0
 33 34  1  0
 32 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5219557

    ---

Associated Targets(Human)

A-427 (643 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DAN-G (242 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SISO (82 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RT-4 (268 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 470.58Molecular Weight (Monoisotopic): 470.2543AlogP: 3.52#Rotatable Bonds: 6
Polar Surface Area: 111.40Molecular Species: NEUTRALHBA: 9HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 5.49CX LogP: 5.48CX LogD: 5.47
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.44Np Likeness Score: -1.11

References

1. Shahari MSB, Dolzhenko AV..  (2022)  A closer look at N2,6-substituted 1,3,5-triazine-2,4-diamines: Advances in synthesis and biological activities.,  241  [PMID:35981459] [10.1016/j.ejmech.2022.114645]

Source